Sterne Agee Group’s Novartis NVS Stock Holding History

Sterne Agee Group’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	$4.07M	Sell	45,165 -25	-0.1%	-$2.22K	0.6%	45
2014 Q4	$3.75M	Buy	45,190 +15,310	+51%	+$1.27M	0.58%	44
2014 Q3	$2.5M	Buy	29,880 +904	+3%	+$73.1K	0.4%	78
2014 Q2	$2.35M	Buy	28,976 +6,023	+26%	+$474K	0.39%	78
2014 Q1	$1.75M	Buy	22,953 +11,362	+98%	+$828K	0.34%	93
2013 Q4	$835K	Buy	11,591 +4,709	+68%	+$327K	0.28%	100
2013 Q3	$473K	Buy	6,882 +1,747	+34%	+$116K	0.18%	131
2013 Q2	$325K	Buy	+5,135	New	+$334K	0.12%	172

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

BTS

BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MAA

Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Sterne Agee Group's NVS Position: Q1 2015 in Review

Sterne Agee Group reduced its Novartis (NVS) stake by 0.06% in Q1 2015, selling an estimated $2.22K and leaving 45,165 shares worth $4.07M. The position accounts for 0.6% of the portfolio, ranked #45.

Sterne Agee Group first reported a position in NVS in Q2 2013 and has held it in 8 quarters since. 939 funds tracked by Wall St. Rank hold NVS as of Q1 2015.

Sterne Agee Group held 45,165 shares of Novartis worth $4.07M as of Q1 2015.
Sterne Agee Group sold 25 Novartis shares in Q1 2015, an estimated $2.22K.
Novartis made up 0.6% of Sterne Agee Group's portfolio in Q1 2015, its #45 holding.
Sterne Agee Group first reported a position in Novartis in Q2 2013 and has held it in 8 quarters since.
939 funds tracked by Wall St. Rank held Novartis as of Q1 2015.

Based on Sterne Agee Group's 13F filing for Q1 2015, filed 13 May 2015.